Skip to main content
. 2022 Oct 31;9:978345. doi: 10.3389/fmed.2022.978345

Table 4.

Factors associated with receiving guidelines compliant prescriptions.

Variables Guidelines compliant Rx No. (%) Univariate analysis Multivariate analysis
OR (95%CI) p -value OR (95%CI) p -value
Gender
Male 113 (40.9) Referent -
Female 74 (42.5) 1.067 (0.727–1.568) 0.739 -
Old age*
No 145 (44.5) Referent Referent
Yes 42 (33.9) 0.639 (0.415–0.984) 0.042 1.379 (0.767–2.479) 0.284
Body mass index (kg/m2)
Underweight (<18.5) 2 (25.0) Referent
Normal (18.5–24.9) 32 (46.4) 2.595 (0.489–13.766) 0.263 -
Overweight (25.0–29.9) 97 (46.0) 2.553 (0.504–12.938) 0.258 -
Obese (>30.0) 56 (34.6) 1.585 (0.310–8.111) 0.580 -
Comorbidities
No 86 (47.8) Referent Referent
1–2 35 (46.1) 0.933 (0.545–1.597) 0.801 1.301 (0.729–2.323) 0.374
>2 66 (34.0) 0.564 (0.371–0.855) 0.007 1.500 (0.756–2.974) 0.246
Hypertension
No 43 (45.3) Referent -
Yes 144 (40.0) 0.825 (0.523–1.302) 0.409 -
Dyslipidemia
No 92 (44.9) Referent
Yes 95 (38.0) 0.778 (0.534–1.134) 0.191 -
Chronic kidney diseases
No 165 (45.3) Referent Referent
Yes 22 (25.6) 0.415 (0.245–0.702) 0.001 0.422 (0.214–0.830) 0.012
Cardiovascular diseases
No 150 (44.6) Referent Referent
Yes 37 (32.5) 0.596 (0.381–0.932) 0.023 0.849 (0.448–1.610) 0.617
Stroke
No 175 (43.6) Referent Referent
Yes 12 (24.5) 0.419 (0.212–0.827) 0.012 0.506 (0.236–1.084) 0.080
Other diseases
No 146 (42.9) Referent
Yes 41 (37.3) 0.790 (0.507–1.229) 0.295
Type of therapy
Monotherapy 72 (59.5) Referent Referent
Polytherapy 115 (35.0) 0.366 (0.238–0.561) <0.001 0.367 (0.218–0.617) <0.001

CI, confidence interval; Kg/m2, kilogram per square meter; OR, odds ratio; Rx, prescription.

*

Old age (>55 years for males, ≥65 years for females).